Global Fungal Testing Equipment Market is expected to see substantial growth, reaching US$ 4504 million by 2033, according to FMI’s analysis

Fungal Testing Equipment Market
Fungal Testing Equipment Market

The global fungal testing equipment market is poised for significant expansion in the coming decade, with a projected Compound Annual Growth Rate (CAGR) of 10.1% between 2023 and 2033. According to market analysts at Future Market Insights, the industry is anticipated to reach an impressive US$ 4504 million by 2033, showcasing a robust trajectory.

As of 2023, the Fungus Testing Kits Market is estimated to be valued at over US$ 1.72 billion, reflecting a substantial market presence. Diagnostic laboratories are expected to play a pivotal role, holding a sizable market share of more than 51.8% in 2023, as highlighted in the predictions by Future Market Insights.

Discover Our Expert Analysis with Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-12418

This growth is driven by an increasing awareness of fungal infections and the need for accurate and timely diagnostics. Fungal testing equipment, including advanced Fungus Testing Kits, is becoming instrumental in identifying and addressing these infections effectively.

Commenting on this remarkable growth trajectory, Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) stated, “The increasing prevalence of fungal infections worldwide has heightened the demand for sophisticated and reliable fungal testing equipment. Our commitment to providing cutting-edge solutions positions Future Market Insights at the forefront of this industry, contributing to improved diagnostics and patient care.”

As a leading player in the fungal testing equipment sector, Future Market Insights continues to innovate and invest in research and development to address the evolving needs of healthcare professionals and diagnostic laboratories globally. The company remains dedicated to enhancing the accuracy and efficiency of fungal infection diagnostics through state-of-the-art technology.

Manufacturers of Fungal Diagnostic Kits Have Numerous Opportunities:

The development of PCR techniques has enabled scientists to find novel genes, gene expression, and genetic mutation in an organism’s tissues, which has controlled the comparative examination of illnesses and normal tissues, and this may raise demand for fungal testing kits.

Expanding healthcare research and development expenditures and the adoption of molecular diagnostic testing provide the profit potential for the growth of the fungal testing kits market.

Challenges Blocking Demand for Fungal Testing Kits:

Poor social awareness of infections, particularly in low and middle-income nations such as India, Africa, Columbia, Mexico, and China, has led to seeking medical help from office-based healthcare setups that profess to treat the disease naturally using traditional remedies.

These societal factors have a significant impact on the transmission of sexually transmitted illnesses and genital diseases. Among the many possible causes are lack of education, poverty, and social inequality. These factors inhibit the fungal testing kits market growth.

Regional Outlook:

The fungal testing kits market has positioned North America as the global powerhouse. As infectious diseases are so common, this is understandable. There is a greater demand for fungal testing kits due to the increased awareness of numerous fungal infections in this area.

The fungal testing kits industry is expanding in Asia-Pacific. With rising healthcare costs and a large patient base, these countries hold great growth potential. These previously mentioned countries are also rife with infections like candidiasis and invasive fungal illnesses. The fungus testing equipment market is growing as a result of this.

Our Analyst Is Here To Assist You With Any Questions Get In Touch Now! https://www.futuremarketinsights.com/ask-question/rep-gb-12418

Key Takeaways:

  • The market’s molecular test segment forecasts a CAGR of 7.5% from 2023 to 2033 in the test type category.
  • The fungal testing kits industry’s diagnostic laboratory sector is likely to experience a CAGR of 7.4% between 2023 and 2033.
  • By 2033, the United States fungus testing equipment market to advance at a CAGR of 9.8% and reach US$ 1210.95 million.
  • By 2033, the China fungal testing kits industry may have climbed at a CAGR of 12.9% and be worth US$ 488.22 million.
  • By 2033, the Canadian market may have expanded by 8.4% CAGR to reach a value of US$105.55 million.
  • By 2033, the German fungal testing kits industry can have risen rapidly to 12.6% and be valued at US$ 352.17 million.
  • The market in the United Kingdom is to evolve at a CAGR of 9.8% and reach US$ 250.61 million by 2033.

Fungal Testing Kits Business Forecast for the Future:

Thermo Fisher Scientific, PerkinElmer Inc., ELITech Group, Merck KGaA, bioMerieux SA, GenMark Diagnostics Incorporation, C.P.M. Diagnostic Research, F.Hoffman LaRoche Limited., PCRmax, Bioquochem, Norgen Biotek, Biomed Diagnostics Incorporation, and Hologic Inc. are among the major fungal testing kits manufacturers.

To develop profitable diagnostic kits, companies are focused on partnerships, collaborations, and acquisitions.

Crucial Strategic Innovations:

Acquisition:

  • ELITech Group acquired the medical goods business Gonotec GmbH on July 14, 2021.
  • Thermo Fisher Scientific officially confirmed the acquisition of Brammer Bio in 2019. This acquisition aided Thermo Fisher Scientific in expanding its laboratory services and product line for fungus testing equipment.

Innovative Strategies Unveiled: Customization at the Core of Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-12418

Key Segments:

By Test Type:

  • Molecular Test
  • Chromogenic Test
  • Others

By Sample Type:

  • Skin
  • Urine
  • Vaginal secretions
  • Blood
  • Cerebral
  • Others

By Application:

  • Research
  • Susceptibility Testing
  • Medical Diagnosis
  • Others

By End User:

  • Diagnostic Laboratory
  • Hospitals
  • Pharmaceutical Companies
  • Research and Academic Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Physiotherapy Equipment Market is poised for significant expansion, with forecasts indicating a possible US$ 38,134.8 Million valuation by 2033

Physiotherapy Equipment Market
Physiotherapy Equipment Market

It is anticipated that the global physiotherapy equipment market demand would grow from US$ 20,367.16 million in 2023 to US$ 38,134.8 million by 2033. The physiotherapy equipment market is expected to increase at a 6.5% CAGR from 2023 to 2033.

The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly.

The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-12409

Globally, the market for physiotherapy equipment is expanding significantly due to reasons like an ageing population, growing public awareness of the value of physical treatment, and rising healthcare costs. Additionally, the importance of remote and home-based physiotherapy services has been underlined by the COVID-19 pandemic, boosting the demand for portable and user-friendly equipment.

The growth of healthcare providers is one of the main factors propelling the physiotherapy industry:

A surge in rehab facilities, road accidents, and injuries are expected to enhance the demand for physiotherapy equipment. Unhealthy eating habits and a harried lifestyle, which can cause discomfort in the ligaments, nerves, muscles, back, and neck as well as an increase in the prevalence of stroke and Parkinson’s disease, are predicted to drive the market. Doctors have started advocating physical therapy to patients since it provides additional benefits, which has raised demand for physical therapy supplies.

Physical therapy, commonly known as physiotherapy, is a type of treatment designed to restore and improve healthy bodily function. It makes use of a range of technology and techniques to assist individuals in maintaining their health and recovering significantly from medical conditions. These therapies often take place in outpatient facilities and are more thorough. Patients who are under observation following surgery, however, often only undergo inpatient rehabilitation therapy.

Should You Have Any Queries, Our Analyst Is Here To Assist You https://www.futuremarketinsights.com/ask-question/rep-gb-12409

Key Points from the Physiotherapy Equipment Market:

  • Market Growth: The physiotherapy equipment market has been experiencing significant growth in recent years. Factors such as the rising prevalence of chronic diseases, an aging population, increasing awareness about the benefits of physiotherapy, and advancements in technology have contributed to market expansion.
  • Types of Equipment: The market encompasses a wide range of equipment used in physiotherapy settings. Some commonly used equipment includes therapeutic exercise equipment (treadmills, stationary bikes, etc.), electrotherapy equipment (ultrasound, TENS units, etc.), heat and cold therapy equipment, traction equipment, and other assistive devices.
  • Rehabilitation Centers and Hospitals: Physiotherapy equipment is widely utilized in rehabilitation centers and hospitals. These settings often require a diverse range of equipment to cater to various patient needs, such as post-operative rehabilitation, musculoskeletal disorders, sports injuries, and neurological conditions.
  • Homecare Settings: The demand for physiotherapy equipment in homecare settings is also growing. Patients who prefer to receive physiotherapy treatments at home, especially the elderly or those with mobility issues, often require portable or compact devices for their therapy sessions.
  • Technological Advancements: The physiotherapy equipment market has witnessed significant technological advancements. These include the integration of advanced features such as data tracking, wireless connectivity, cloud-based platforms, and remote monitoring capabilities. Such innovations help improve treatment outcomes and enhance patient experience.
  • Regional Markets: The physiotherapy equipment market exhibits regional variations. North America, Europe, and Asia Pacific are significant markets due to the presence of well-established healthcare infrastructure, rising healthcare expenditure, and increasing awareness about physiotherapy benefits. Emerging economies in Latin America and Africa are also showing growth potential.

Customize Your Knowledge: Unlock Targeted Insights to Drive Growth in the Physiotherapy Equipment Market! https://www.futuremarketinsights.com/customization-available/rep-gb-12409

Key Developments in the Physiotherapy Equipment Market:

  • August 2022 – The Assam Down Town University (AdtU)  opened new physiotherapy labs, including a Gait Lab, an Electromyography studies lab, and a Pulmonary function test lab with spirometers.
  • July 2022 – Indutrade struck an agreement to acquire all the shares of the Swedish company Primed Fysio och Rehab AB. Primed is a Swedish company that sells professional physiotherapy equipment.
  • February 2022 – Colfax Corp announced the renewal of its collaboration with the Professional Football Athletic Trainer Society (PFATS), allowing the firm to endorse and recommend its products to certified athletic trainers.
  • January 2022 – BTL Industries bought Schepp MedTech. This acquisition was made to add robots to BTL’s already extensive physiotherapy product offering.

Key Companies in the Global Physiotherapy Equipment Market:

  • BTL
  • EMS Physio Ltd.
  • Dynatronics Corporation
  • RICHMAR
  • Performance Health
  • Storz Medical AG
  • Zimmer Medizin System GmbH
  • ITO Co., Ltd.
  • Enraf-Nonius B.V.
  • Whitehall Manufacturing
  • DJO Global
  • EMS Physio
  • Zynex Medical Inc.
  • Patterson Medical

Get Ahead with Detailed Market Intelligence: Purchase Now to Access! https://www.futuremarketinsights.com/checkout/12409

Key Segmentation:

Product:

  • Laser Therapy Equipment
  • Continuous Passive Motion Devices
  • Transcutaneous Electrical Neural Stimulator (TENS)
  • Interferential Stimulator (IFT)
  • Electrical Muscle Stimulator (EMS)
  • High Voltage Pulsed Galvanic Stimulator (HVPGS)
  • Ultrasound Therapy Equipment
  • Traction Equipment
  • Diathermy Equipment
  • Exercise Equipment

Equipment Type:

  • Cryotherapy
  • Hydrotherapy
  • Electrotherapy
  • Continuous Passive Motion Units
  • Multi-exercise Therapy Unit
  • Heat Therapy
  • Ultrasound Physiotherapy
  • Other Therapy Types

Application:

  • Neurological
  • Musculoskeletal
  • Cardiovascular and Pulmonary
  • Others

End User:

  • Hospitals
  • Rehabilitation Centers/Clinics
  • Homecare Settings

Region:

  • North America
  • Latin America
  • Europe
  • The Middle East & Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Nanoscale Chemicals Market Projected to Reach US$ 11.84 Billion by 2032, Driven by 9% CAGR Surge

The global nanoscale chemicals market is poised for substantial growth, projected to reach a valuation of US$ 11.84 billion by 2032. With a notable compound annual growth rate (CAGR) of 9% anticipated during the forecast period, this market segment is experiencing significant expansion. As of 2022, it stands at a valuation of US$ 5 billion, reflecting its current momentum and potential for future development driven by advancements in nanotechnology and increasing demand across various industries.

The nanoscale chemicals market is characterized by its dynamic nature, fueled by continuous research and development efforts worldwide. These chemicals typically range in size from 1 to 100 nanometers, conferring them with distinctive physical, chemical, and biological properties. Nanoparticles, nanotubes, nanofibers, and quantum dots are among the key constituents of this burgeoning market, finding applications across various sectors including electronics, healthcare, energy, and environmental remediation.

Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-943

Key Drivers and Trends:

  1. Demand for Advanced Materials: Industries are increasingly seeking materials with enhanced properties such as strength, conductivity, and catalytic activity. Nanoscale chemicals offer a promising solution by enabling precise control over material properties at the atomic and molecular levels.
  2. Healthcare Innovations: Nanotechnology holds immense potential in revolutionizing healthcare through targeted drug delivery, imaging agents, and diagnostic tools. Nanoscale chemicals play a crucial role in these applications by improving the efficacy and specificity of medical interventions while minimizing side effects.
  3. Environmental Sustainability: Nanotechnology presents opportunities for mitigating environmental challenges through pollution control, water purification, and renewable energy technologies. Nanoscale chemicals contribute to these efforts by facilitating efficient catalysts, sensors, and remediation agents for environmental applications.
  4. Technological Convergence: The convergence of nanotechnology with other cutting-edge fields such as artificial intelligence, biotechnology, and quantum computing is driving innovation at an unprecedented pace. Nanoscale chemicals serve as building blocks for interdisciplinary solutions with far-reaching implications.

Nanoscale Chemicals Market: Key Players

  • Qinhuangdao Taiji Ring Nano-Products Co., Ltd.
  • NanoMas Technologies
  • Akzo Nobel/Eka
  • BASF
  • Tokuyama
  • Nanophase technologies
  • Altair Nanotechnologies
  • Carbon Nanotechnologies
  • Advanced Nano Products.

Contact Sales for Further Assistance in Purchasing this Report: https://www.futuremarketinsights.com/checkout/943

Nanoscale Chemicals Market: Segmentation

The global nanoscale chemicals market can be segmented by end-use industry, by material type, and by regions

Based on end-use industry type

  • Automotive
  • Electronics
  • Electrical
  • Medical
  • Others

Based on region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Precocious Puberty Treatment Market Targets US$ 3,650.66 Million by 2033

Precocious Puberty Treatment Market
Precocious Puberty Treatment Market

Over the course of the projected year, the global premature puberty treatment market share is expected to develop at a compound annual growth rate (CAGR) of 7.8%, from an astounding valuation of US$ 1,716.43 million in 2023 to US$ 3,650.66 million by 2033. Getting product approval from regulatory agencies such as the US Food and Drug Administration (FDA) is the main focus of leading industry players. This is expected to propel the market’s growth during the estimated period.

For example, in May 2020, Tolmar Pharmaceuticals, Inc., a pharmaceutical company, received authorization and approval for its New Drug Application from the Unites states FDA for FENSOLVI (leuprolide acetate) for injectable suspension for the treatment of pediatric patients aged two years and older with precocious puberty. This is projected to propel market growth during the forecast period.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16582

Likewise, these players are focusing on a number of inorganic strategies such as partnerships, mergers, and agreements, which is expected to drive the precocious puberty market growth during the forecast period. For example, in January 2016, Debiopharm International SA (Debiopharm) which is a part of Debiopharm Group, made an agreement for exclusive distribution agreement with Arbor Pharmaceuticals, a pharmaceutical company, for the commercialization and promotion of triptorelin 22.5 mg for Central precocious puberty treatment.

On the other hand, surging research and development activities in triptorelin for applications in several therapeutic indications, by private manufacturers and research organizations is fuelling growth of precocious puberty treatment market. Moreover, the higher efficacy and tolerability of triptorelin in the suppression of gonadotropin secretion in prostate cancer and precocious puberty is surging the adoption of triptorelin in the market which is anticipated to benefit the market of precocious puberty.

Also, the engagement by key players in expanding their product portfolio in several geographical areas is expected to aid market growth. For example, in October 2017, Arbor Pharmaceuticals, LLC and Debiopharm International SA commercialized availability of Triptodur (triptorelin), in the United States for the treatment of pediatric patients two years and older diagnosed with Precocious Puberty. Furthermore, reimbursement for the treatment of precocious puberty is provided through Medicaid, which is estimated to offer lucrative growth prospects for the global precocious puberty market during the forecast period.

Key Takeaways:

  • North America is expected to dominate the industry while reaching market share of around 46.7% by end of the forecast period.
  • The market in East Asia is projected to account for 25% market share by end of the projected period.
  • By drug class, ‘triptorelin’ is projected to account for 62% market share by end of the forecast period.
  • Hospitals are expected to dominate the market by distribution channel, with a market share of 58% by 2033.

“Increasing rate of product approvals, surging growth in mergers and acquisitions between companies, and development of new drugs will increase the product demand for treatment of precocious puberty,” comments an FMI analyst.

Competitive Landscape

The precocious puberty treatment market is extremely competitive and consists of various key market players. These players are developing novel delivery systems for treating precocious puberty. This is anticipated to fuel precocious puberty treatment market. The key players in this market are: Teva Pharmaceutical Industries Ltd, AbbVie Inc., Arbor Pharmaceuticals, LLC, Pfizer Inc, Tolmar Pharmaceuticals, Inc., Endo International plc, Ipsen Pharma, Debiopharm Group, Sun Pharmaceutical Industries Limited, Sanofi

Key industry players are inclined on adoption of inorganic growth strategies like acquisition, partnerships, and collaboration in order to bolster their product portfolio. This is expected to propel the global precocious puberty treatment market.

  • In June, 2020, Ipsen Pharma undergone strategic partnership with Debiopharm for Decapeptyl (triptorelin) for another 15 years. Decapeptyl (triptorelin) is used for treating central precocious puberty in children. This strategic merger helped the company to maintain a continuous product access to patients.
  • In March 2022, Accord BioPharma, the United States special division of Intas Pharmaceuticals, Ltd. declared the United States launch of CAMCEVI (leuprolide) 42mg injection emulsion for the treatment of progressive prostate cancer in adults.In February 2022, BDR Pharmaceuticals revealed its brand ENZALUTAMIDE, an antiandrogen in 160mg with brand name BDENZA for treatment of Prostate Cancer patients.
  • In January 2019, Debiopharm group informed about an agreement with Allergan to begin a transition process for Trelstar (Triptorelin pamoate) intended to lead to new licensees taking over the commercialization of Trelstar in the United States and Canada and the termination of Allergan’s partnership with Debiopharm for strategic reasons.

Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-16582

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cold Plasma Market is forecasted to experience US$ 9380.9 million by 2033, with advancements in healthcare and food processing highlighted as crucial by FMI

Cold Plasma Market
Cold Plasma Market

Future Market Insights, a leading player in the thrilled to announce the impressive growth projections for the global cold plasma market, according to estimates by Future Market Insights (FMI). The data suggests that the net worth of total cold plasma to be sold worldwide is anticipated to generate a substantial revenue of US$ 2469.5 million in 2023.

FMI’s research further highlights the robust trajectory of the global cold plasma market, indicating a projected market size of US$ 9380.9 million by 2033. This growth is expected to occur at a remarkable Compound Annual Growth Rate (CAGR) of 14.3%. The expanding market reflects the increasing adoption of cold plasma technology across various industries, showcasing its versatility and impact.

To Get The Sample Copy Of Report Visit! https://www.futuremarketinsights.com/reports/sample/rep-gb-12401

Cold plasma technology, especially in the form of portable devices, has gained significant traction across medicinal, bioengineering, and food processing sectors. This innovative technology offers a range of applications in these fields, contributing to enhanced efficiency, safety, and quality standards.

One noteworthy application of cold plasma is in the life sciences domain, where atmospheric pressure cold plasma has found diverse applications. Researchers and industry professionals have recorded numerous successful applications, demonstrating the technology’s potential in various life sciences applications.

Future Market Insights has been at the forefront of leveraging cold plasma technology to create cutting-edge solutions that address the evolving needs of our clients. With a commitment to innovation and excellence, Future Market Insights continues to play a pivotal role in shaping the landscape of the global cold plasma market.

“We are excited about the immense potential of cold plasma technology, and our team at Future Market Insights remains dedicated to pushing the boundaries of what is possible. The FMI estimates underscore the growing importance of cold plasma in diverse sectors, and we are well-positioned to capitalize on this trend,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

As Future Market Insights continues to drive innovation in the cold plasma space, the company looks forward to contributing significantly to the projected market growth and maintaining its leadership position in the industry.

Key Takeaways:

  • Low temperature atmospheric pressure plasma to capture the lion’s share during the forecast period
  • Food processing & packaging slated to expand impressively due to increased awareness regarding food contamination due to surface pathogens
  • Administration for healing chronic wounds to experience immense white spaces in terms of application
  • North America to retain market hegemony, Asia-Pacific offer lucrative prospects in the textile industry

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-12401

Competitive Intelligence:

Prominent players within the global cold plasma market include:

  • Nordson Corporation
  • Europlasma NV
  • Plasmatreat GmBh
  • Terraplasma Medical GmBh
  • Henniker Plasma
  • US Medical Innovations
  • Molecular Plasma Group
  • Nordson Corporation
  • Adtech Plasma Technology Co Ltd.
  • Smith & Nephew plc.
  • Thierry Corporation

In February 2020, Adtech Plasma Technology initiated a new project in collaboration with Hull York Medical School for testing gas plasma on osteomyelitis bone infections. The project will assist in establishing a laboratory testing model for evaluating and optimizing plasma treatment for osteomyelitis biofilm infections.

Plasma treat has deployed a prototype cleaning station in conjunction with the Bavarian Red Cross for disinfecting single-use protective clothing for frontline COVID-19 healthcare workers.

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the keyword market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
  • Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-12401

Cold plasma Market: Segmentation:

Regime Type:

  • Low-pressure
  • Atmospheric pressure

Application:

  • Wound Healing
  • Cancer Treatment
  • Blood Coagulation
  • Dentistry
  • Packaging Decontamination
  • Food Surface Decontamination
  • Wastewater Treatment
  • Seed Germination

Technology:

  • Remote Treatment
  • Direct Treatment
  • Electrode Contact

End-user:

  • Medical Industry
  • Textile Industry
  • Electrical & Electronic Industry
  • Food & Agriculture Industry

Region:

  • North America
  • Latin America
  • Europe
  • Middle East & Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Anatomic Pathology Market is projected to witness substantial growth, with FMI predicting an 8.2% CAGR by 2030

Anatomic Pathology Market
Anatomic Pathology Market

The global anatomic pathology market is witnessing substantial growth, with a valuation of US$ 32.5 Million in 2022 and a projected robust CAGR of 8.2% from 2022 to 2030. By the end of the decade, the market is anticipated to surpass US$ 61.1 Million. Future Market Insights leader, is strategically positioned to capitalize on this accelerating trend.

The upward trajectory in the anatomic pathology market is attributed to the increasing application of anatomic pathology in disease diagnosis and the dynamic field of drug discovery and development. Future Market Insights is at the forefront of innovation, leveraging cutting-edge technology and a commitment to excellence to meet the evolving demands of the healthcare and pharmaceutical sectors.

To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

As a key player in the market, Future Market Insights is well-poised to play a pivotal role in advancing anatomic pathology solutions. With a strong focus on quality, accuracy, and efficiency, Future Market Insights is dedicated to providing state-of-the-art diagnostic tools and services that contribute to enhanced patient outcomes and accelerate drug development processes.

“We are thrilled to witness the remarkable growth in the global anatomic pathology market, and Future Market Insights is committed to driving innovation and delivering unparalleled solutions to meet the evolving needs of healthcare professionals and researchers worldwide,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Key Takeaways:

  • The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030
  • Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents
  • Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination
  • Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

In Case Of Any Queries, Don’t Hesitate To Contact Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-12370

Key Participant Insights:

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance:

  • In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
  • In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.
  • In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

Key companies profiled:

  • Laboratory Corporation of America Holdings
  • Sakura Finetek USA, Inc.
  • F.Hoffmann-La Roche AG
  • Cardinal Health, Inc.
  • BioGenex
  • NeoGenomics
  • Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology industry globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology industry during the assessment period.

The Europe anatomic pathology industry is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Personalized Experiences Redefined: Our Customization Report Holds the Answers! https://www.futuremarketinsights.com/customization-available/rep-gb-12370

Key Segments of Anatomic Pathology Industry Survey:

Anatomic Pathology Industry by Product & Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

Anatomic Pathology Industry by Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic Pathology Industry by End User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Anatomic Pathology Industry by Region:

  • North America Anatomic Pathology Industry
  • Latin America Anatomic Pathology Industry
  • Europe Anatomic Pathology Industry
  • East Asia Anatomic Pathology Industry
  • South Asia & Pacific Anatomic Pathology Industry
  • Middle East & Africa (MEA) Anatomic Pathology Industry

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Endometrial Ablation Market Surges Past US$ 6.8 Billion Valuation by 2033

Endometrial Ablation Market
Endometrial Ablation Market

According to a recently published Future Market Insights study, the endometrial ablation market sales is predicted to reach US$ 3.4 billion in sales in 2023 and rise at a compound annual growth rate (CAGR) of 7.3% between 2023 and 2033. By the end of 2033, it is projected that the market will reach US$ 6.8 billion. The total GDP of the US and China in 2022 was US$ 1.4 billion.

Endometrial ablation is a medical procedure designed to treat abnormal uterine bleeding by removing or destroying the lining of the uterus, known as the endometrium. This technique is often considered for women who experience heavy menstrual bleeding (menorrhagia) that doesn’t respond well to other treatments like medications. By targeting the endometrial lining, the procedure aims to reduce or eliminate menstrual bleeding, offering relief to those who suffer from this debilitating condition.

Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-16577

The endometrial ablation procedure is minimally invasive, and it is usually performed on an outpatient basis. It offers several advantages compared to more invasive surgical options like hysterectomy. Some benefits of endometrial ablation include shorter recovery times, lower risks of complications, and the preservation of the uterus. This is particularly important for women who still wish to have children in the future.

With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.

The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by ABillionormal Uterine Bleeding. Women’s treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women’s health at the center of their wellbeing race.

In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women’s healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.

Key players:

  • Medtronic
  • CooperSurgical Inc.
  • Boston Scientific Corp.
  • Ethicon, Inc.
  • Olympus Corp.
  • Richard Wolf GmbH
  • AngioDynamics
  • Hologic, Inc.
  • Minerva Surgical, Inc.

Elevate Strategy: Tap into Analyst Expertise Now:
https://www.futuremarketinsights.com/ask-question/rep-gb-16577
A few of the recent developments in the market are:

  • In February 2021, CooperSurgical, a division of CooperCompanies, acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
  • In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
  • In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division’s worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
  • In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific’s electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company’s offerings.

Key Segments:

By Type:

  • Devices
    • Cryoablation
    • Radiofrequency Ablation
    • Hydrothermal Ablation
    • Thermal Balloon
    • Microwave Energy
  • Procedures

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

Unleash Potential: Craft Your Customized Report Now :
https://www.futuremarketinsights.com/customization-available/rep-gb-16577

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Sinus Therapeutic Drugs Market could achieve a valuation of US$ 6.35 Billion by 2032, propelled by increasing demands | FMI

Sinus Therapeutic Drugs Market
Sinus Therapeutic Drugs Market

The global sinus therapeutic drugs market demand is anticipated to reach US$ 4.29 billion in 2022, reach US$ 6.35 billion by 2032, and grow at a CAGR of 4% through 2032. The market for sinus therapeutic drugs globally is anticipated to grow at a CAGR of over 6.3% between 2020 and 2030.

The global sinus therapeutic drugs market is experiencing significant growth and evolution, driven by the increasing prevalence of sinus-related disorders and a growing awareness of the available treatment options. Sinusitis, a common ailment affecting millions worldwide, has prompted a surge in the demand for therapeutic drugs aimed at alleviating its symptoms and providing long-term relief. This market segment encompasses a wide range of pharmaceutical products, including antibiotics, decongestants, corticosteroids, and saline solutions, all designed to address the various aspects of sinusitis.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-12367

One of the key drivers of this market’s expansion is the rising incidence of chronic sinusitis. Factors such as environmental pollution, allergies, and lifestyle choices have contributed to the surge in cases, leading individuals to seek effective therapeutic solutions. Additionally, advancements in medical research have paved the way for innovative drug formulations, providing more efficient and targeted treatments.

Another noteworthy trend in the Sinus Therapeutic Drugs Industry is the increasing preference for non-invasive treatment options. Nasal sprays, for instance, have gained popularity due to their ease of use and minimal side effects, as opposed to surgical interventions. Moreover, the market is witnessing a growing interest in herbal and natural remedies, reflecting a broader shift towards holistic healthcare practices.

The Sinus Therapeutic Drugs Industry is also benefiting from a proactive approach to healthcare, with individuals seeking early diagnosis and treatment. As healthcare systems worldwide emphasize preventive care, patients are more likely to consult healthcare professionals at the onset of sinus symptoms, thus driving the demand for therapeutic drugs.

The Sinus Therapeutic Drugs Industry is poised for continuous growth as sinus-related disorders continue to affect a significant portion of the global population. With advancements in pharmaceuticals, a preference for non-invasive treatments, and a proactive healthcare approach, this market is expected to expand further in the coming years. As researchers continue to explore innovative solutions and patients become increasingly health-conscious, the market’s potential for development remains promising.

Key Factors Driving The Sinus Therapeutic Drugs Industry Include:

  • Prevalence of Sinusitis: Sinusitis is a widespread condition, affecting millions of people worldwide. The high prevalence of sinusitis contributes to the demand for therapeutic drugs.
  • Increasing Allergies: Allergies can exacerbate sinus problems, and as allergies become more common, there is a growing need for medications to manage sinus symptoms in allergic individuals.
  • Rising Pollution Levels: Environmental factors such as pollution can worsen sinus conditions. As pollution levels increase in many urban areas, the demand for sinus therapeutic drugs may also rise.
  • Advancements in Drug Development: Ongoing research and development efforts are leading to the introduction of more effective and targeted drugs for sinus conditions.
  • Aging Population: An aging population is more susceptible to sinus issues, as sinus problems tend to become more common with age. This demographic trend increases the potential market for sinus therapeutic drugs.
  • Patient Awareness and Healthcare Access: Improved patient awareness of sinus conditions and better access to healthcare services contribute to the growing demand for treatment options.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-12367

The Sinus Therapeutic Drugs Industry Includes Various Types Of Medications, Including:

  • Antibiotics: Used to treat bacterial sinus infections.
  • Decongestants: Help relieve nasal congestion and swelling.
  • Antihistamines: Useful for managing sinus symptoms associated with allergies.
  • Corticosteroids: Reduce inflammation in the sinus passages.
  • Nasal Irrigation Solutions: Non-medication options that can help flush out mucus and relieve symptoms.
  • Pain Relievers: Such as acetaminophen or ibuprofen for pain relief.

Additionally, surgical interventions may be considered for severe or chronic cases of sinusitis that do not respond well to medications. These interventions may include sinus surgery to improve drainage or remove obstructions.

The Major Players In The Sinus Therapeutic Drugs Industry Include:

  • Sun Pharmaceutical Industries, Inc.
  • Reddy’s Laboratories, Inc.
  • Novartis AG
  • Tea Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Fresenius Kabi USA
  • Janssen Pharmaceuticals, Inc.

Customization Unleashed: Learn How to Stand Out in a Competitive Landscape! https://www.futuremarketinsights.com/customization-available/rep-gb-12367

Key Segmentation Sinus Therapeutic Drugs Industry:

Route of Administration:

  • Oral
  • Topical
  • Injectable

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Disease Type:

  • Acute Sinusitis
  • Sub-acute Sinusitis
  • Chronic Sinusitis

Geography:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Agro Textiles Market Projected to Achieve Remarkable 6.4% CAGR by 2033

The global agro textiles market is poised for robust growth, projected to achieve an impressive double-digit compound annual growth rate (CAGR) of 6.4% to reach a market value of US$ 9,478 million. This anticipated expansion underscores the increasing adoption of agro textiles across various agricultural applications worldwide, driven by their benefits such as enhanced crop protection, soil erosion control, and improved water conservation practices, among others. With escalating demands for sustainable agricultural practices and advancements in textile technologies, the market is expected to witness substantial growth in the coming years.

The agro textiles market has been experiencing significant growth worldwide, driven by factors such as the increasing adoption of modern agricultural practices, rising demand for high-quality crops, growing awareness about the benefits of agro textiles, and government initiatives promoting sustainable farming techniques. According to recent market research reports, the global agro textiles market is projected to continue expanding at a steady pace over the forecast period.

Transform Your Strategy: Request a Sample Report to Elevate Your Business! https://www.futuremarketinsights.com/reports/sample/rep-gb-11747

Market Trends:

Several trends are shaping the agro textiles market, including:

  1. Sustainable Farming Practices: With growing concerns about environmental degradation and resource depletion, there is increasing demand for agro textiles that support sustainable farming practices, such as water conservation, reduced chemical usage, and soil preservation.
  2. Technological Advancements: Ongoing research and development efforts are leading to the introduction of advanced agro textiles with enhanced functionalities, such as UV resistance, thermal insulation, and anti-microbial properties, catering to the evolving needs of farmers.
  3. Vertical Farming: The rising popularity of vertical farming techniques, especially in urban areas with limited arable land, is driving the demand for specialized agro textiles designed for vertical cultivation systems.
  4. Market Expansion in Emerging Economies: Growing agricultural activities in emerging economies, coupled with increasing investments in infrastructure development and modernization of farming practices, are creating lucrative opportunities for agro textile manufacturers in regions such as Asia-Pacific, Latin America, and Africa.

Agro Textiles Market: Top Key Players

  • Diatex
  • Neo Corp International Limited
  • Belton Industries Inc.
  • Capatex
  • Beaulieu Technical Textiles
  • B&V Agro Irrigation Co.

Unlock the potential for future growth by requesting your personalized custom report Now! https://www.futuremarketinsights.com/customization-available/rep-gb-11747

Agro Textiles Market: Segmentation

The Global Market of Agro Textiles can be segmented by Product Type:

  • Fishing nets
  • Mulch mats
  • Shade nets
  • Anti-hail nets and bird protection nets
  • Others

The Global Market of Agro Textiles can be segmented by Fiber:

  • Nylon
  • Polyester
  • Polyethylene
  • Polyolefin
  • Polypropylene
  • Jute
  • Wool

The Global Market of Agro Textiles can be segmented by Application:

  • Crop Production
  • Horticulture, Floriculture and Forestry
  • Animal Husbandry and Aqua Culture
  • Agro Engineering

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Veterinary Imaging Market will likely achieve a valuation of US$ 3.37 Billion by 2030, according to FMI

Veterinary Imaging Market
Veterinary Imaging Market

The global veterinary imaging market is poised for substantial growth in the coming years, with a projected Compound Annual Growth Rate (CAGR) of 6.6% from 2022 to 2030, according to the latest market research. This surge is anticipated to propel the market valuation from US$ 2.02 Billion in 2022 to an impressive US$ 3.37 Billion by 2030.

Future Market Insights, a leading player in the veterinary imaging sector, is strategically positioned to capitalize on this positive trend. With a steadfast commitment to innovation and cutting-edge technologies, Future Market Insights stands at the forefront of providing state-of-the-art solutions to veterinarians and animal healthcare professionals worldwide.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

The global veterinary imaging market encompasses a wide array of diagnostic modalities, including radiography, ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). The increasing prevalence of pet ownership, coupled with a growing awareness of advanced veterinary diagnostic tools, is fueling the demand for veterinary imaging services worldwide.

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) expressed optimism about the industry’s growth potential, stating, “We are excited about the robust projections for the global veterinary imaging market. As a pioneer in this sector, FMI is well-positioned to leverage these opportunities. Our commitment to advancing veterinary diagnostics aligns with the evolving needs of the industry, and we remain dedicated to providing cutting-edge solutions that enhance animal healthcare.”

The company’s comprehensive portfolio of veterinary imaging products, combined with a strong focus on research and development, positions Future Market Insights as a key player in driving advancements in veterinary diagnostics. The anticipated market expansion presents FMI with an excellent opportunity to further strengthen its global presence and contribute to the overall improvement of animal healthcare.

Key Takeaways:

  • Animal healthcare being a costly affair, people are shifting their gears to pet insurance
  • The veterinary imaging market is driven by an ever-increasing number of veterinarians adopting imaging devices with reagents associated with them, which include PET, MRI, X-Ray radiology devices, and CT scanners
  • Multi-slice CT scan systems expected to drive the market in the forecast period
  • Asia-Pacific is slowly picking up with people turning the tide in favour of pet care
  • Adoption of magnetic resonance imaging (MRI) systems continue to grow at a steady pace

“Technological advancements along with inorganic expansion are creating new strides for the veterinary imaging market. These trends are bound to catapult the veterinary imaging market to growth between 2022 and 2030”- says the FMI analyst.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-12368

List of Key Players Covered in Veterinary Imaging Industry are:

  • Esaote
  • IDEXX Laboratories, Inc.
  • IMV Technologies group
  • Carestream Health
  • Hallmarq Veterinary Imaging Ltd.
  • MinXray, Inc.
  • Universal Medical Systems, Inc.
  • Agfa- Gevaert N.V.
  • Mindray Medical International Ltd.
  • GE Healthcare
  • Siemens AG

The key market players are emphasizing on creating awareness about veterinary imaging devices to enter the untapped markets. For instance – in Oct 2018, GE Healthcare announced having inked a strategic agreement with SonoSim for encouraging training regarding ultrasound services.

Key Segments:

Veterinary Imaging Industry by Product Type:

  • Veterinary Imaging Equipment
    • Radiography (X-ray) Systems
      • Computed Radiography
      • Film-based Radiography
    • Ultrasound Imaging Systems
      • 2D US Imaging
      • 3D US Imaging
    • Magnetic Resonance Imaging Systems
    • Computed Tomography Systems
      • Single-slice CT
      • Multi-slice CT
    • Video Endoscopy Imaging Systems
    • Others
  • Veterinary Imaging Software
  • Veterinary Imaging Reagents
    • Ultrasound Contrast Reagents
    • MRI Contrast Reagents
    • X-Ray/CT Contrast Reagents
    • Nuclear Imaging Reagents

Veterinary Imaging Industry by Animal Type:

  • Small Animals
  • Large Animals

Veterinary Imaging Industry by Application:

  • Cardiology
  • Orthopedics
  • Neurology
  • Oncology
  • Others

Veterinary Imaging Industry by End User:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Institutes and Research Centers

Veterinary Imaging Industry by Region:

  • North America Veterinary Imaging Industry
  • Latin America Veterinary Imaging Industry
  • Europe Veterinary Imaging Industry
  • East Asia Veterinary Imaging Industry
  • South Asia & Pacific Veterinary Imaging Industry
  • Middle East & Africa (MEA) Veterinary Imaging Industry

Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-12368

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube